Suppr超能文献

SAK是一种新的类polo样激酶,受p53转录抑制,RNA干扰沉默时可诱导细胞凋亡。

SAK, a new polo-like kinase, is transcriptionally repressed by p53 and induces apoptosis upon RNAi silencing.

作者信息

Li Jun, Tan Mingjia, Li Ling, Pamarthy Deepika, Lawrence Theodore S, Sun Yi

机构信息

Department of Radiation Oncology, University of Michigan Comprehensive Cancer Center, 4304 CCGC, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0936, USA.

出版信息

Neoplasia. 2005 Apr;7(4):312-23. doi: 10.1593/neo.04325.

Abstract

Chip profiling of a p53 temperature-sensitive tumor model identified SAK (Snk/Plk-akin kinase), encoding a new member of polo-like kinases (PLKs), as a gene strongly repressed by wild-type p53. Further characterization revealed that SAK expression was downregulated by wild-type p53 in several tumor cell models. Computer search of a 1.7-kb SAK promoter sequence revealed three putative p53 binding sites, but p53 failed to bind to any of these sites, indicating that SAK repression by p53 was not through a direct p53 binding to the promoter. Transcriptional analysis with luciferase reporters driven by SAK promoter deletion fragments identified SP-1 and CREB binding sites, which together conferred a two-fold SAK repression by p53. However, the repression was not reversed by cotransfection of SP-1 or CREB, suggesting a lack of interference between p53 and SP-1 or CREB. Significantly, p53-mediated SAK repression was largely reversed in a dose-dependent manner by Trichostatin A, a potent histone deacetylase (HDAC) inhibitor, suggesting an involvement of HDAC transcription repressors in SAK repression by p53. Biologically, SAK RNA interference (RNAi) silencing induced apoptosis, whereas SAK overexpression attenuated p53-induced apoptosis. Thus, SAK repression by p53 is likely mediated through the recruitment of HDAC repressors, and SAK repression contributes to p53-induced apoptosis.

摘要

对一个p53温度敏感肿瘤模型进行芯片分析,鉴定出SAK(Snk/Plk家族激酶)是一种由野生型p53强烈抑制的基因,该基因编码polo样激酶(PLK)的一个新成员。进一步的特征分析表明,在几种肿瘤细胞模型中,野生型p53下调了SAK的表达。对1.7 kb的SAK启动子序列进行计算机搜索,发现了三个假定的p53结合位点,但p53未能与这些位点中的任何一个结合,这表明p53对SAK的抑制并非通过p53直接与启动子结合。用SAK启动子缺失片段驱动的荧光素酶报告基因进行转录分析,鉴定出SP-1和CREB结合位点,它们共同导致p53对SAK的抑制作用增强了两倍。然而,共转染SP-1或CREB并不能逆转这种抑制作用,这表明p53与SP-1或CREB之间不存在干扰。值得注意的是,一种有效的组蛋白脱乙酰酶(HDAC)抑制剂曲古抑菌素A以剂量依赖的方式在很大程度上逆转了p53介导的SAK抑制作用,这表明HDAC转录抑制因子参与了p53对SAK的抑制作用。从生物学角度来看,SAK RNA干扰(RNAi)沉默诱导细胞凋亡,而SAK过表达则减弱了p53诱导的细胞凋亡。因此,p53对SAK的抑制作用可能是通过招募HDAC抑制因子介导的,并且SAK抑制作用有助于p53诱导的细胞凋亡。

相似文献

3
Transcriptional regulation of the human DNA polymerase delta catalytic subunit gene POLD1 by p53 tumor suppressor and Sp1.
J Biol Chem. 2001 Aug 10;276(32):29729-39. doi: 10.1074/jbc.M101167200. Epub 2001 May 25.
4
p53-dependent repression of polo-like kinase-1 (PLK1).
Cell Cycle. 2010 Oct 15;9(20):4200-12. doi: 10.4161/cc.9.20.13532. Epub 2010 Oct 4.
5
p53 and its downstream proteins as molecular targets of cancer.
Mol Carcinog. 2006 Jun;45(6):409-15. doi: 10.1002/mc.20231.
7
Function of polo-like kinase 3 in NF-kappaB-mediated proapoptotic response.
J Biol Chem. 2005 Apr 29;280(17):16843-50. doi: 10.1074/jbc.M410119200. Epub 2005 Jan 25.
9
p53-dependent down-regulation of telomerase is mediated by p21waf1.
J Biol Chem. 2004 Dec 3;279(49):50976-85. doi: 10.1074/jbc.M402502200. Epub 2004 Sep 15.

引用本文的文献

1
Centriole Duplication at the Crossroads of Cell Cycle Control and Oncogenesis.
Cells. 2025 Jul 17;14(14):1094. doi: 10.3390/cells14141094.
3
The fate of extra centrosomes in newly formed tetraploid cells: should I stay, or should I go?
Front Cell Dev Biol. 2023 Jul 27;11:1210983. doi: 10.3389/fcell.2023.1210983. eCollection 2023.
5
6
Biomarkers of non-communicable chronic disease: an update on contemporary methods.
PeerJ. 2022 Feb 24;10:e12977. doi: 10.7717/peerj.12977. eCollection 2022.
7
Estrogens-Origin of Centrosome Defects in Human Cancer?
Cells. 2022 Jan 27;11(3):432. doi: 10.3390/cells11030432.
8
Keep Calm and Carry on with Extra Centrosomes.
Cancers (Basel). 2022 Jan 17;14(2):442. doi: 10.3390/cancers14020442.
9
Hypoxia Drives Centrosome Amplification in Cancer Cells via HIF1α-dependent Induction of Polo-Like Kinase 4.
Mol Cancer Res. 2022 Apr 1;20(4):596-606. doi: 10.1158/1541-7786.MCR-20-0798.
10
Polo-Like Kinase 4's Critical Role in Cancer Development and Strategies for Plk4-Targeted Therapy.
Front Oncol. 2021 Mar 12;11:587554. doi: 10.3389/fonc.2021.587554. eCollection 2021.

本文引用的文献

2
Polo-like kinase 1 (Plk1) inhibits p53 function by physical interaction and phosphorylation.
J Biol Chem. 2004 Jun 11;279(24):25549-61. doi: 10.1074/jbc.M314182200. Epub 2004 Mar 15.
3
p53-regulated transcriptional program associated with genotoxic stress-induced apoptosis.
J Biol Chem. 2004 May 14;279(20):21183-92. doi: 10.1074/jbc.M311912200. Epub 2004 Mar 11.
5
Silencing of the novel p53 target gene Snk/Plk2 leads to mitotic catastrophe in paclitaxel (taxol)-exposed cells.
Mol Cell Biol. 2003 Aug;23(16):5556-71. doi: 10.1128/MCB.23.16.5556-5571.2003.
8
Tissue-specific induction of p53 targets in vivo.
Cancer Res. 2002 Dec 15;62(24):7316-27.
9
p53-dependent downregulation of metastasis-associated laminin receptor.
Oncogene. 2002 Oct 24;21(49):7478-87. doi: 10.1038/sj.onc.1205957.
10
SSRP1 functions as a co-activator of the transcriptional activator p63.
EMBO J. 2002 Oct 15;21(20):5487-97. doi: 10.1093/emboj/cdf540.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验